Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors

This publication has 13 references indexed in Scilit:

• (6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitors with Broad Antiproliferative Activity against Tumor Cells
  Journal of Medicinal Chemistry, 2005
• Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. current status and future perspective
  Frontiers in Bioscience-Landmark, 2005
• Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas
  Brain Research Reviews, 2004
• Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
  New England Journal of Medicine, 2004
• The Ester and Amide Derivatives of 4-(4-Methyl Piperazinomethyl) Benzoic Acid
  Synthetic Communications, 2003
• Molecular basis of angiogenesis and cancer
  Oncogene, 2003
• Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications
  Seminars in Oncology, 2002
• Structure-based design and protein X-ray analysis of a protein kinase inhibitor
  Bioorganic & Medicinal Chemistry Letters, 2002
• Mechanisms of angiogenesis
  Nature, 1997
• Angiogenesis in cancer, vascular, rheumatoid and other disease
  Nature Medicine, 1995